Skip to content
Screener

UnitedHealth Group UNH Cash, Cash Equivalents, and Marketable Securities

Cash, Cash Equivalents, and Marketable Securities at other companies

Humana logo
HumanaHUM
$15.36B+18.3%
CVS Health logo
CVS HealthCVS
$14.82B
CNO Financial Group logo
CNO Financial GroupCNO
$9.7B+8.6%
Oscar Health logo
Oscar HealthOSCR
$6.08B+119%

Other financials

Income statement

See full
Revenue$112.03B+0.4%
Gross profit$98.7B+0.1%
Operating income$8.0B+55.2%
Net income$5.5B+61.0%
EPS (diluted)$6.04+61.5%

Balance sheet

See full
Cash & equivalents$28.6B0.0%
Total debt$73.3B-7.4%
Total equity$104.51B+4.0%
Total assets$309.73B+0.4%

Cash flow

See full
Operating cash flow$11.1B+53.8%
CapEx$799.0M-9.8%
Free cash flow$10.3B+62.7%

Valuation

See full
Market cap$369.69B+61.5%
Enterprise value$414.43B+48.3%
P/E26.2×+15.4×
P/S0.8×+0.3×

Profitability

See full
Gross margin88.6%+0.3pp
Operating margin4.8%-2.5pp
Net margin3.1%-1.9pp
FCF margin5.2%-0.7pp

Returns & leverage

See full
Return on equity13.8%-8.0pp
Debt / equity0.7×-0.1×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by UnitedHealth Group in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The source filing: UnitedHealth Group’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000731766-26-000197
(in millions) / June 30, 2026Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Corporate obligations28,89272(703)28,261
U.S. agency mortgage-backed securities10,93913(684)10,268
Non-U.S. agency mortgage-backed securities3,2594(105)3,158
Total debt securities - available-for-sale52,069109(1,893)50,285
Debt securities - held-to-maturity:
U.S. government and agency obligations448(2)446
State and municipal obligations25(2)23
Corporate obligations33

Item 1. Financial Statements (unaudited)

FAQ

What is UnitedHealth Group's cash, cash equivalents, and marketable securities?
UnitedHealth Group (UNH) reported cash, cash equivalents, and marketable securities of $50.29B in Q2 2026.
How has UnitedHealth Group's cash, cash equivalents, and marketable securities changed year-over-year?
UnitedHealth Group's cash, cash equivalents, and marketable securities increased by 7.9% year-over-year, from $46.61B to $50.29B.
What is the long-term trend for UnitedHealth Group's cash, cash equivalents, and marketable securities?
Over 5 years (2020 to 2025), UnitedHealth Group's cash, cash equivalents, and marketable securities has grown at a 3.9% compound annual growth rate (CAGR), from $39.83B to $48.18B.
What does cash, cash equivalents, and marketable securities mean?
This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term investments that can be readily converted into cash. It serves as the primary buffer for operational liquidity and potential capital allocation activities. Investors monitor this to assess the company's ability to meet short-term obligations and fund growth initiatives.

Ask your AI about UnitedHealth Group's cash, cash equivalents, and marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude